{"id":10903,"date":"2020-07-29T23:23:24","date_gmt":"2020-07-30T04:23:24","guid":{"rendered":"https:\/\/www.billingparadise.com\/blog\/?p=10903"},"modified":"2023-03-16T04:01:52","modified_gmt":"2023-03-16T09:01:52","slug":"top-drugs-of-2026","status":"publish","type":"post","link":"https:\/\/www.billingparadise.com\/blog\/top-drugs-of-2026\/","title":{"rendered":"Top Drugs Of 2026"},"content":{"rendered":"<section  class=\"section no\"><div class=\"row\"><div class=\"wpb_column col-md-12 have-padding\"><div class=\"text-block \" ><div class=\"simple-text \"><p>&nbsp;<\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Drug<\/b><\/td>\n<td><b>Company<\/b><\/td>\n<td><b>Projected Sales<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Keytruda\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400\">Merck<\/span><\/td>\n<td><span style=\"font-weight: 400\">$24.9 billion\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Opdivo\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400\">Bristol Myers Squibb<\/span><\/td>\n<td><span style=\"font-weight: 400\">$12.7 billion\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Eliquis<\/span><\/td>\n<td><span style=\"font-weight: 400\">Bristol Myers Squibb<\/span><\/td>\n<td><span style=\"font-weight: 400\">$12.6 billion<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\"> Biktarvy<\/span><\/td>\n<td><span style=\"font-weight: 400\">Gilead<\/span><\/td>\n<td><span style=\"font-weight: 400\">$11.7 billion\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Imbruvica<\/span><\/td>\n<td><span style=\"font-weight: 400\">AbbVie + Johnson &amp; Johnson<\/span><\/td>\n<td><span style=\"font-weight: 400\">$10.7 billion<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Ibrance\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400\">Pfizer<\/span><\/td>\n<td><span style=\"font-weight: 400\">$9.7 billion\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Tagrisso<\/span><\/td>\n<td><span style=\"font-weight: 400\">AstraZeneca<\/span><\/td>\n<td><span style=\"font-weight: 400\">$9.5 billion<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Dupixent<\/span><\/td>\n<td><span style=\"font-weight: 400\">Sanofi<\/span><\/td>\n<td><span style=\"font-weight: 400\">$9.4 billion\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Trikafta<\/span><\/td>\n<td><span style=\"font-weight: 400\">Vertex Pharmaceuticals<\/span><\/td>\n<td><span style=\"font-weight: 400\">$8.7 billion\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Ozempic\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400\">Novo Nordisk<\/span><\/td>\n<td><span style=\"font-weight: 400\">$8.3 billion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"&nbsp; Drug Company Projected Sales Keytruda\u00a0 Merck $24.9 billion\u00a0 Opdivo\u00a0 Bristol Myers Squibb $12.7 billion\u00a0 Eliquis Bristol Myers Squibb $12.6 billion Biktarvy Gilead $11.7 billion\u00a0 Imbruvica AbbVie + Johnson &amp; Johnson $10.7 billion Ibrance\u00a0 Pfizer $9.7 billion\u00a0 Tagrisso AstraZeneca $9.5 billion Dupixent Sanofi $9.4 billion\u00a0 Trikafta Vertex Pharmaceuticals $8.7 billion\u00a0 Ozempic\u00a0 Novo Nordisk $8.3 billion","protected":false},"author":2,"featured_media":10897,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[911],"tags":[],"class_list":["post-10903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts\/10903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/comments?post=10903"}],"version-history":[{"count":1,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts\/10903\/revisions"}],"predecessor-version":[{"id":442221,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts\/10903\/revisions\/442221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/media\/10897"}],"wp:attachment":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/media?parent=10903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/categories?post=10903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/tags?post=10903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}